Back to research feed

Seminars in radiation oncology

July 1, 2026 · via Europe PMC

Integrative Oncology in Practice: Moving the SIO-ASCO Guidelines From Evidence to Implementation.

Metri NA, Hundal J, Rao S, Paller CJ.

ReviewAbstract only — full text under license

AI summary — for doctors, generated from the abstract only

SIO-ASCO guidelines support selected integrative therapies for pain, fatigue, depression and anxiety, but implementation remains limited, and a 'carrot and stick' framework is proposed to improve adoption.

What was studied

Review summarizing SIO-ASCO integrative oncology guidelines and strategies to overcome implementation barriers.

Key findings

  • Guidelines cover pain, cancer-related fatigue, depression and anxiety
  • Implementation in routine practice remains limited
  • Proposes incentive and accountability strategies plus practical integration approaches

Clinical relevance

This review may help oncology practices, including radiation oncology, operationalize guideline-supported integrative therapies.

Who should care

Radiation Oncology

Limitations

Narrative review; no new outcome data.

Evidence-based integrative therapies are guideline-endorsed but still underused in routine care.

This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.

Abstract

The Society for Integrative Oncology (SIO) and the American Society of Clinical Oncology (ASCO) collaboratively developed evidence-based guidelines supporting selected integrative therapies for common cancer-related symptoms, specifically pain, cancer-related fatigue, depression, and anxiety. Despite growing evidence supporting their use, implementation in routine oncology practice remains limited. In this review, we summarize the SIO-ASCO guidelines and examine barriers to their implementation in clinical settings. We then explore strategies to improve guideline adherence using a "carrot and stick" framework that combines incentive-based approaches with accountability mechanisms. Finally, we present practical strategies to integrate the SIO-ASCO guidelines into routine clinical care. We conclude by discussing future directions for implementing integrative oncology in real-world clinical settings. These approaches aim to overcome the barriers associated with guideline adoption in clinical practice, supporting the widespread use of evidence-based integrative therapies across academic and community settings, improving patient symptom management and quality of life, and ensuring equitable access to integrative therapies for all patients. Together, these efforts will help to establish integrative oncology as a standard part of routine cancer care.

DOI

10.1016/j.semradonc.2026.151036

PMID

42288362

Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.

Want more like this?

Browse more from the feed. A free account unlocks the full feed, saving and communities.

Back to the research feed

Create a free account · Sign in